Drug interactions
Dabigatran etexilate + Doxorubicin liposomal
Severity: Minor
Dabigatran etexilate and Doxorubicin liposomal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Doxorubicin is a P-gp substrate and is not an established P-gp inducer, so a clinically relevant reduction in dabigatran exposure is not expected. The legacy claim is not supported by clear pharmacology; however, chemotherapy-related thrombocytopenia may independently raise bleeding risk with any anticoagulant.
What this interaction means in plain words
Dabigatran etexilate and Doxorubicin liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
No established mechanism; doxorubicin is not a recognized P-gp inducer.
What to do
No dabigatran dose change is needed for this interaction. Monitor platelet counts and renal function during chemotherapy and review anticoagulation if thrombocytopenia occurs.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dabigatran etexilate and Doxorubicin liposomal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Dabigatran etexilate
- Dabigatran etexilate + Defibrotide Contraindicated
- Dabigatran etexilate + Ketorolac Contraindicated
- Dabigatran etexilate + Mifepristone Contraindicated
- Abciximab + Dabigatran etexilate Major
- Alteplase + Dabigatran etexilate Major
- Amiodarone + Dabigatran etexilate Major
Frequently asked questions
Can I take Dabigatran etexilate with Doxorubicin liposomal?
MediHelp rates the interaction as minor. Dabigatran etexilate and Doxorubicin liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Doxorubicin is a P-gp substrate and is not an established P-gp inducer, so a clinically relevant reduction in dabigatran exposure is not expected. The legacy claim is not supported by clear pharmacology; however, chemotherapy-related thrombocytopenia may independently raise bleeding risk with any anticoagulant.
How serious is the interaction between Dabigatran etexilate and Doxorubicin liposomal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dabigatran dose change is needed for this interaction. Monitor platelet counts and renal function during chemotherapy and review anticoagulation if thrombocytopenia occurs.
What other medicines interact with Dabigatran etexilate?
MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
